These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 27033387)
21. Pathologic patterns of invasive carcinoma associated with intraductal papillary neoplasms of bile duct (IPNB). Nakanuma Y; Sugino T; Kakuda Y; Okamura Y; Uesaka K; Nomura Y; Watanabe H; Terada T; Fukumura Y; Ohnishi Y; Sato Y Ann Diagn Pathol; 2022 Dec; 61():152055. PubMed ID: 36279801 [TBL] [Abstract][Full Text] [Related]
22. Intraductal papillary neoplasm of the bile duct, gastric type, arising in the intrapancreatic common bile duct could progress to colloid carcinoma: report of a case. Tajima S; Ohata A; Koda K; Maruyama Y Int J Clin Exp Pathol; 2015; 8(5):5848-55. PubMed ID: 26191308 [TBL] [Abstract][Full Text] [Related]
23. Gastric subtype of intraductal papillary neoplasm of the bile duct: The pathologic spectrum. Nakanuma Y; Uesaka K; Terada T; Fukumura Y; Sugino T; Kakuda Y; Ikeda H; Harada K; Sato Y; Shimizu S; Matsukuma S; Kee Taek J; Nyun Park Y J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):402-413. PubMed ID: 32356328 [TBL] [Abstract][Full Text] [Related]
24. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas. Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028 [TBL] [Abstract][Full Text] [Related]
25. A Review of Type 1 and Type 2 Intraductal Papillary Neoplasms of the Bile Duct. Huang XH; Chen TX; Liu HL; Huang MW Curr Med Sci; 2024 Jun; 44(3):485-493. PubMed ID: 38748369 [TBL] [Abstract][Full Text] [Related]
26. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct. Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577 [TBL] [Abstract][Full Text] [Related]
27. Intraductal tubular neoplasms of the bile ducts. Katabi N; Torres J; Klimstra DS Am J Surg Pathol; 2012 Nov; 36(11):1647-55. PubMed ID: 23073323 [TBL] [Abstract][Full Text] [Related]
28. Intraductal papillary neoplasms of the bile duct. Ohtsuka M; Shimizu H; Kato A; Yoshitomi H; Furukawa K; Tsuyuguchi T; Sakai Y; Yokosuka O; Miyazaki M Int J Hepatol; 2014; 2014():459091. PubMed ID: 24949206 [TBL] [Abstract][Full Text] [Related]
29. Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas. Ohtsubo I; Ajiki T; Hori Y; Murakami S; Shimizu K; Itoh T; Shimizu M; Fukumoto T; Ku Y Hepatol Res; 2012 Jun; 42(6):574-82. PubMed ID: 22221899 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the Clinicopathologic Characteristics of Intraductal Papillary Neoplasm of the Bile Duct according to Morphological and Anatomical Classifications. Kim JR; Lee KB; Kwon W; Kim E; Kim SW; Jang JY J Korean Med Sci; 2018 Oct; 33(42):e266. PubMed ID: 30310366 [TBL] [Abstract][Full Text] [Related]
31. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes. Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct. Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359 [TBL] [Abstract][Full Text] [Related]
33. Morphological classification of intraductal papillary neoplasm of the bile duct. Ying S; Ying M; Liang W; Wang Z; Wang Q; Chen F; Xiao W Eur Radiol; 2018 Apr; 28(4):1568-1578. PubMed ID: 29138880 [TBL] [Abstract][Full Text] [Related]
34. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics]. Schlitter AM; Klöppel G; Esposito I Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621 [TBL] [Abstract][Full Text] [Related]
35. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma. Kubo S; Tanaka S; Kinoshita M; Shinkawa H; Ishizawa T; Sato Y Virchows Arch; 2023 Apr; 482(4):745-753. PubMed ID: 36715769 [TBL] [Abstract][Full Text] [Related]
36. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations. Nakanuma Y; Uesaka K; Kakuda Y; Sugino T; Kubota K; Furukawa T; Fukumura Y; Isayama H; Terada T J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317146 [TBL] [Abstract][Full Text] [Related]
37. [Magnetic resonance imaging features and classification of intraductal papillary neoplasm of the bile duct]. Liu LC; Chen YF; Shan YQ; Chen LL; Zeng MS; Wang ML Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):461-468. PubMed ID: 38858196 [No Abstract] [Full Text] [Related]
38. Intraductal papillary neoplasm of the bile ducts: A case report and literature review. Tan Y; Milikowski C; Toribio Y; Singer A; Rojas CP; Garcia-Buitrago MT World J Gastroenterol; 2015 Nov; 21(43):12498-504. PubMed ID: 26604656 [TBL] [Abstract][Full Text] [Related]
39. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI. Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. Sasaki M; Matsubara T; Yoneda N; Nomoto K; Tsuneyama K; Sato Y; Nakanuma Y Histopathology; 2013 Feb; 62(3):446-57. PubMed ID: 23163606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]